Publications by authors named "Harry Thomas Temple"

Sarcomas are malignancies of mesenchymal origin that occur in bone and soft tissues. Many are chemo- and radiotherapy resistant, thus conventional treatments fail to increase overall survival. Natural Killer (NK) cells exert anti-tumor activity upon detection of a complex array of tumor ligands, but this has not been thoroughly explored in the context of sarcoma immunotherapy.

View Article and Find Full Text PDF

Background/aim: Restoration of gait mechanics after reconstruction have been associated with improved functional outcomes and increased longevity of the reconstruction. The goal of this study is to compare the gait mechanics of an allograft reconstruction of the distal femur to both metallic endoprosthetic reconstruction relative to normal control subjects.

Methods: Gait parameters were captured using motion capture system, and then analyzed and compared for patients with metallic endoprosthetic reconstructions, and patients with allograft reconstructions of the distal femur following resection of malignant bone tumor, with subjects having no history of musculoskeletal disorders serving as a control group.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Harry Thomas Temple"

  • Harry Thomas Temple's research primarily focuses on the intersection of immunology and orthopedic reconstruction, specifically exploring innovative treatment modalities for sarcoma and the functional outcomes of limb reconstruction.
  • His 2021 study on natural killer (NK) cells highlights their potential in targeting sarcoma, emphasizing the need for further exploration in immunotherapy due to the resistance of these tumors to conventional treatments.
  • Additionally, his 2015 article assesses gait mechanics between metallic endoprosthetic and allograft reconstructions in distal femoral replacements, underlining the importance of functional recovery post-surgery for enhanced patient outcomes.